PRMT5 and systemic sclerosis: Furthermore, patients with SSc with elevated APR levels, defined as having at least one of the following, CRP ≥6 mg/L, ESR ≥28 mm per hour or platelet count ≥330×109/L, showed higher serum levels of anti-PRMT5, compared with the patients with SSc without APR elevation (figure 5B).